Authors: Flatt, Shirley W, Health, Dennis D, Natarajan, Loki, Pakiz, Bilge, Quintana, Elizabeth L, Rana, Brinda K, Rock, Cheryl L
Published: January 1, 2017
A 12-month randomized controlled trial enrolled 242 overweight/obese women into three diet arms. The lower fat arm (20% energy from fat, 65% from carbohydrate) reduced plasma IL-6 levels measured at baseline, 6, and 12 months. Baseline IL-6 levels were 2.04–2.72 pg/mL depending on genotype group, with the CC genotype group having significantly lower baseline BMI (32.5 vs. 33.6 kg/m², p = 0.03). IL-6 reductions occurred across all diet arms without significant diet-by-genotype interaction, confirming that this lower-fat approach effectively reduces breast cancer-associated inflammation when paired with weight loss.
